MPI 5011

Drug Profile

MPI 5011

Alternative Names: Fluorouracil therapeutic implant; IntraDose-FU

Latest Information Update: 20 Feb 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chiron Corporation
  • Class Antineoplastics
  • Mechanism of Action Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Head and neck cancer; Liver cancer; Prostate cancer

Most Recent Events

  • 31 Dec 1998 Suspended-II for Liver cancer in USA (Intratumoural)
  • 31 Dec 1998 Suspended-II for Prostate cancer in USA (Intratumoural)
  • 31 Dec 1998 Suspended-III for Head and neck cancer in USA (Intratumoural)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top